Search - tctmd.com

Displaying 21 - 38 of 38

Sort: Relevancy | Date

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Features

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

Todd Neale

November 02, 2020

News Daily News

Echo Aids Diagnosis, Risk Prediction in Severe COVID-19

Shelley Wood

October 26, 2020

News Daily News

Open Letter Calls on CV Societies to Discourage CMR After Mild COVID-19

Shelley Wood

September 15, 2020

News Daily News

Both CV Risk Factors, Complications Herald Higher COVID-19 Mortality

Shelley Wood

August 19, 2020

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2020

Shelley Wood

July 02, 2020

News Daily News

Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists

Shelley Wood

May 14, 2020

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Opinion Editor's Corner

COVID-19 and the Heart: Insights From the Front Lines

Shelley Wood

March 12, 2020

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

News Daily News

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Shelley Wood

November 02, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Caitlin E. Cox

July 30, 2018

News Daily News

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

Todd Neale

March 25, 2018

News Conference News ESC 2016

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

Shelley Wood

August 28, 2016

News Daily News

Most Late Cardiac Mortality After TAVR Due to Heart Failure, Sudden Cardiac Death

Yael L. Maxwell

February 02, 2015

News Daily News

Shock-Wave Preconditioning Boosts Cell Therapy for Chronic Heart Failure

L.A. McKeown

April 19, 2013

Advertisement

May 2021 News Roundup

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

Echo Aids Diagnosis, Risk Prediction in Severe COVID-19

Open Letter Calls on CV Societies to Discourage CMR After Mild COVID-19

Both CV Risk Factors, Complications Herald Higher COVID-19 Mortality

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

TCTMD’s Top 10 Most Popular Stories for June 2020

Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

COVID-19 and the Heart: Insights From the Front Lines

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

Most Late Cardiac Mortality After TAVR Due to Heart Failure, Sudden Cardiac Death

Shock-Wave Preconditioning Boosts Cell Therapy for Chronic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content